Peter Hume Chapman - 16 Jun 2025 Form 4 Insider Report for IonQ, Inc. (IONQ)

Signature
/s/ Stacey Giamalis, Attorney-in-Fact
Issuer symbol
IONQ
Transactions as of
16 Jun 2025
Transactions value $
-$170,943,138
Form type
4
Filing time
18 Jun 2025, 21:00:04 UTC
Previous filing
13 Jun 2025
Next filing
20 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chapman Peter Hume Executive Chair, Director C/O IONQ, INC., 4505 CAMPUS DRIVE, COLLEGE PARK /s/ Stacey Giamalis, Attorney-in-Fact 18 Jun 2025 0001885490

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONQ Common Stock Options Exercise $478K +3.58M +917.48% $0.13 3.97M 16 Jun 2025 Direct F1
transaction IONQ Common Stock Sale -$137M -3.58M -90.17% $38.13 390K 16 Jun 2025 Direct F1, F2
transaction IONQ Common Stock Options Exercise $121K +911K +233.33% $0.13 1.3M 17 Jun 2025 Direct F1
transaction IONQ Common Stock Sale -$34.4M -911K -70% $37.78 390K 17 Jun 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONQ Employee Stock Option (right to buy) Options Exercise -$478K -3.58M -58.74% $0.13 2.52M 16 Jun 2025 Common Stock 8.1M $0.14 Direct F4
transaction IONQ Employee Stock Option (right to buy) Options Exercise -$121K -911K -36.2% $0.13 1.6M 17 Jun 2025 Common Stock 8.1M $0.14 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.0450 to $39.1450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.87 to $38.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 All of the shares subject to this option are fully vested and exercisable as of the date hereof